▪ Biocon Biologics Limited’s (BBL) acquisition of Viatris’ rights in biosimilars assets, creates a unique global, vertically integrated biosimilars leader…
Browsing: Biocon Biologics
Biocon Biologics to manufacture and commercialise a broadly neutralising antibody for India and select emerging Markets Antibody treatment based on…
Amritsar, NFAPost: Biocon Biologics has announced a global collaboration agreement with Voluntis to develop and distribute digital therapeutics supporting people…